Collegium Pharmaceutical, Inc.
COLL
$36.05
$1.253.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.16% | 162.93% | 395.78% | -80.72% | 34.29% |
| Total Depreciation and Amortization | -0.19% | -0.18% | 0.08% | 0.09% | 35.37% |
| Total Amortization of Deferred Charges | -4.99% | -0.89% | -0.88% | -4.00% | 17.88% |
| Total Other Non-Cash Items | 703.81% | -128.90% | -22.29% | 507.81% | -198.95% |
| Change in Net Operating Assets | 497.87% | -45.00% | 62.66% | -193.43% | 126.28% |
| Cash from Operations | 56.87% | 8.28% | 30.76% | -34.55% | 1,040.59% |
| Capital Expenditure | -266.49% | -189.23% | 91.85% | -40.00% | -133.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.83% | -976.49% | 67.91% | 20.64% | -159.47% |
| Cash from Investing | 34.98% | -958.94% | 69.89% | 17.70% | 95.28% |
| Total Debt Issued | -- | -- | -- | -- | -96.22% |
| Total Debt Repaid | -3,536.32% | 0.00% | 0.00% | 0.00% | 90.19% |
| Issuance of Common Stock | -57.02% | 644.16% | -85.03% | 1,089.60% | -72.10% |
| Repurchase of Common Stock | 10.68% | 96.22% | -141.03% | 58.14% | -17,719.72% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -1,161.26% | 95.31% | -- |
| Cash from Financing | -47.26% | 69.37% | -91.67% | 38.86% | -127.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.80% | 54.83% | 3.28% | -35.19% | 129.01% |